Economic burden of multiple sclerosis in the United States: A systematic literature reviewMarion Schauf, Daniel M. Hartung, Seema Dimri et al.|Journal of Managed Care & Specialty Pharmacy|2023Cited by 23
Budget Impact Analysis of Biosimilar Natalizumab in the USEdward Li, Daniel M. Hartung, Adrian Goh et al.|The American Journal of Managed Care|2024Cited by 4